Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia

Allison Ashley-Koch, Erin R. Bonner, P. Craig Gaskell, Sandra G. West, Richard Tim, Chantelle M. Wolpert, Rodney Jones, Carolyn D. Farrell, Martha Nance, Ingrid K. Svenson, Douglas A. Marchuk, Rose Mary N. Boustany, Jeffery M. Vance, William K. Scott, Margaret A. Pericak-Vance

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


We evaluated seven families segregating pure, autosomal dominant familial spastic paraplegia (SPG) for linkage to four recently identified SPG loci on chromosomes 2q (1), 8q (2), 12q (3), and 19q (4). These families were previously shown to be unlinked to SPG loci on chromosomes 2p, 14q, and 15q. Two families demonstrated linkage to the new loci. One family (family 3) showed significant evidence for linkage to chromosome 12q, peaking at D12S1691 (maximum lod=3.22). Haplotype analysis of family 3 did not identify any recombinants among affected individuals in the 12q candidate region. Family 5 yielded a peak lod score of 2.02 at marker D19S868 and excluded linkage to other known SPG loci. Haplotype analysis of family 5 revealed several crossovers in affected individuals, thereby potentially narrowing the SPG12 candidate region to a 5-cM region between markers D19S868 and D19S220. Three of the families definitively excluded all four loci examined, providing evidence for further genetic heterogeneity of pure, autosomal dominant SPG. In conclusion, these data confirm the presence of SPG10 (chromosome 12), potentially reduce the minimum candidate region for SPG12 (chromosome 19q), and suggest there is at least one additional autosomal dominant SPG locus.

Original languageEnglish (US)
Pages (from-to)91-97
Number of pages7
Issue number2
StatePublished - 2001
Externally publishedYes


  • Autosomal dominant familial spastic paraplegia
  • Chromosome 12q
  • Chromosome 19q
  • Linkage

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)


Dive into the research topics of 'Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia'. Together they form a unique fingerprint.

Cite this